Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Pneumologie ; 71(4): 215-220, 2017 Apr.
Article in German | MEDLINE | ID: mdl-28407675

ABSTRACT

Extracorporeal CO2 removal (ECCO2R) is becoming an increasingly established treatment option for patients with acute severe hypercapnic respiratory failure. Technically, pumpless arterio-venous systems using the natural arterio-venous pressure gradient and also pump-driven veno-venous systems are available. Here, veno-venous ECCO2R has become the preferred technique, as settings for arterio-venous ECCO2R are restricted and side effects are more common with arterio-venous ECCO2R. Using veno-venous ECCO2R with blood flow rates up to 450 ml/min 60 to 80 ml CO2 can be removed per minute corresponding to 20 to 30 % of the total amount of CO2 production. However, in case of very severe hypercapnic respiratory failure with severe respiratory acidosis (pH 7.1 or less) blood flow rates of around 1000 ml/min are required for compensating severe respiratory acidosis corresponding to the elimination of 50 to 60 % of the total amount of CO2 production. Relevant side effects include the activation of blood coagulation and associated bleeding complications. Two recent case-control studies in severely exacerbated COPD patients could demonstrate that intubation rates can be reduced by the application of ECCO2R, but this was associated with non-ignorable side effects. Therefore, randomized controlled trials are urgently needed to more precisely establish the risks and benefits of ECCO2R when aimed at avoiding intubation.


Subject(s)
Blood Coagulation Disorders/prevention & control , Extracorporeal Membrane Oxygenation/methods , Hemorrhage/prevention & control , Hypercapnia/therapy , Respiratory Insufficiency/therapy , Blood Coagulation Disorders/etiology , Evidence-Based Medicine , Extracorporeal Membrane Oxygenation/adverse effects , Hemorrhage/etiology , Humans , Hypercapnia/complications , Hypercapnia/diagnosis , Respiratory Insufficiency/diagnosis , Respiratory Insufficiency/etiology , Treatment Outcome
2.
Gynecol Obstet Fertil Senol ; 46(5): 474-480, 2018 May.
Article in French | MEDLINE | ID: mdl-29709567

ABSTRACT

Many studies have examined the impact of cell/embryo culture media on the development of human embryo during IVF process, but few studies have followed up and compared the effects of these culture media on the developmental outcome of children conceived by IVF. As recurrent experimental evidence from animal studies suggests potential long-term effects of embryo culture media on the health outcome of IVF-conceived children, more studies are needed to clarify the role of the culture media and mechanisms underlying such effects. In human, however, the effects of culture media are difficult to pinpoint due to complications stem from both the influence of maternal nutrition during the gestational period and the parental genetic. Based on a simple review of the literature integrating animal experimentations and human clinic studies, we suggest that the composition of culture medium should be considered beyond the character of unique or sequential medium, corresponding to "let embryo choose" or "back to nature" respectively. Instead, we suggest that the main components of embryo culture media should be considered from the point of view of metabolic consequences and potential epigenetic effects. Given that energetic metabolites can regulate epigenetic machinery, we hypothesize that metabolic abnormalities linked to morphological abnormalities could reveal epigenetic defects in embryos.


Subject(s)
Culture Media , Embryo Culture Techniques/methods , Fertilization in Vitro/methods , Animals , Embryonic Development/physiology , Epigenesis, Genetic , Female , Humans , Infant Health , Infant, Newborn
3.
Hamostaseologie ; 26(2): 123-30, 2006 May.
Article in German | MEDLINE | ID: mdl-16676055

ABSTRACT

The endothelium is of important significance in the development of the acute coronary syndrome. As an endo-/paracrine organ, the endothelium plays a key role in the regulation of the vascular homeostasis. The endothelial integrity and above all the bioavailability of nitric oxide (NO) are essential for the correct function of the endothelium. Cardiac risk factors may lead to an endothelial dysfunction with a consecutive imbalance of the vascular homeostasis. In an inflammatory or prothrombotic state the endothelium shows a number of abnormalities such as oxidative stress, expression of cell adhesion molecules, activation of cell signal-systems (renin-angiotensin-system, CD40/CD40L-system) and especially the loss of NO. The inflammatory cascades lead to coronary atherosclerosis over years or, more instantly, to the acute coronary syndrome caused by endothelial erosion or the rupture of an instable plaque. The knowledge of the pathophysiological processes in the arterial wall during the acute coronary syndrome may lead to the identification of high risk patients and the development of more targeted therapies.


Subject(s)
Blood Vessels/physiopathology , Coronary Disease/physiopathology , Endothelium, Vascular/pathology , Acute Disease , Coronary Circulation , Humans , Models, Cardiovascular , Syndrome
4.
Biochim Biophys Acta ; 1453(1): 14-22, 1999 Jan 06.
Article in English | MEDLINE | ID: mdl-9989241

ABSTRACT

Human tracheal gland serous (HTGS) cells are now believed to be a major target of cystic fibrosis (CF) gene therapy. To evaluate the efficiency of adenovirus-mediated gene transfer in these cells we tested the adenovirus construction containing beta-galactosidase cDNA. We observed that the endogenous beta-galactosidase activity in cultured CF-HTGS cells was too strong to allow us to detect any exogenous beta-galactosidase activity. Immunohistological study on sections of human tracheal tissue confirmed the presence of beta-galactosidase in the serous component of the submucosal glands. We then looked for other lysosomal activities in normal and CF-HTGS cells. We showed that normal cells already have elevated enzyme values and that CF-HTGS cells contained 2-4-fold more beta-galactosidase, alpha-fucosidase, alpha-mannosidase and beta-glucuronidase activities than normal cells. An analysis of their kinetic constants has shown that this difference could be attributed to a lower K(m) of CF lysosomal enzymes. More importantly, these differences are eliminated after adenovirus-mediated CFTR gene transfer and not after beta-galactosidase gene transfer.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Lysosomes/enzymology , Trachea/enzymology , Cells, Cultured , Cystic Fibrosis/enzymology , Cystic Fibrosis/therapy , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Gene Transfer Techniques , Genetic Therapy , Genetic Vectors , Humans , Immunohistochemistry , In Vitro Techniques , Trachea/ultrastructure , beta-Galactosidase/biosynthesis , beta-Galactosidase/genetics
5.
Circulation ; 104(24): 2955-60, 2001 Dec 11.
Article in English | MEDLINE | ID: mdl-11739312

ABSTRACT

BACKGROUND: Sulfatides are sulfated glycosphingolipids present on the surface of oligodendrocytes, renal tubular cells, and certain tumor cells. They appear to be involved in nerve conduction and cell adhesion, but their precise physiological function is not known. METHODS AND RESULTS: Here, we show a novel role for sulfatides as a major ligand for P-selectin in platelet adhesion and aggregation. Sulfatides are expressed on the platelet surface, and platelets expressing sulfatides adhere to P-selectin. Both sulfatide micelles and sulfatide-binding recombinant malaria circumsporozoite protein (MCSP) inhibit this adhesion. In parallel, platelets and CHO cells expressing P-selectin adhere to sulfatides, and anti-P-selectin antibodies inhibit this adhesion. Furthermore, both anti-P-selectin antibodies and sulfatide antagonist MCSP significantly reverse platelet aggregation induced by ADP, collagen, or thrombin receptor-activating peptide, suggesting that sulfatide-P-selectin interactions are necessary for the formation of stable platelet aggregates. CONCLUSIONS: These results show that sulfatide interactions with P-selectin are important in platelet adhesion and platelet aggregation. The sulfatide interactions with P-selectin stabilize platelet aggregates, representing a new mechanism of platelet aggregation that may play a significant role in hemostasis and thrombosis.


Subject(s)
Platelet Aggregation/physiology , Sulfoglycosphingolipids/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Binding, Competitive/drug effects , Blood Platelets/metabolism , CHO Cells , Cell Adhesion/drug effects , Cricetinae , Fibrinogen/immunology , Fibrinogen/metabolism , Humans , P-Selectin/immunology , P-Selectin/metabolism , Platelet Adhesiveness/drug effects , Platelet Aggregation/drug effects , Protozoan Proteins/pharmacology
6.
Circulation ; 102(16): 1931-6, 2000 Oct 17.
Article in English | MEDLINE | ID: mdl-11034941

ABSTRACT

BACKGROUND: P-selectin mediates rolling of platelets and leukocytes on activated endothelial cells. After platelet activation, P-selectin is translocated from intracellular granules to the external membrane, whereas fibrinogen aggregates platelets by bridging glycoprotein (GP) IIb/IIIa between adjacent platelets. METHODS AND RESULTS: In this study, we define a novel role for P-selectin in platelet aggregation. Expression of P-selectin on the platelet surface correlated strongly with the mean platelet aggregate size. Inhibition of P-selectin binding to its ligand by either monoclonal anti-P-selectin antibodies directed against the lectin domain or soluble human P-selectin reversed platelet aggregation even when added up to 5 minutes after activation; however, fibrinogen binding to platelets was not affected. This deaggregating effect significantly reduced the maximal size and number of platelet aggregates. When added 1 minute after platelet activation, anti-P-selectin antibody achieved 95% to 100% of the deaggregating effect of EDTA, whereas the anti-GP IIb/IIIa antibody abciximab had no effect. Monoclonal antibodies against known P-selectin ligands, such as P-selectin GP ligand-1 (PSGL-1) or GP Ib, had no effect on platelet aggregation, suggesting a different ligand for P-selectin in platelet aggregate stabilization. In kinetic studies, P-selectin was maximally expressed 10 minutes after platelet activation, whereas maximal activation of GP IIb/IIIa occurred within the first 10 seconds, suggesting that P-selectin operates after fibrinogen binding to activated GP IIb/IIIa. CONCLUSIONS: These results indicate that P-selectin interaction with a ligand, different from PSGL-1 or GP Ib, stabilizes initial GP IIb/IIIa-fibrinogen interactions, allowing the formation of large stable platelet aggregates.


Subject(s)
Blood Platelets/metabolism , P-Selectin/biosynthesis , Platelet Aggregation/physiology , Abciximab , Adenosine Diphosphate/metabolism , Adenosine Diphosphate/pharmacology , Antibodies, Monoclonal/pharmacology , Blood Platelets/cytology , Edetic Acid/pharmacology , Fluorescent Antibody Technique , Humans , Immunoglobulin Fab Fragments/pharmacology , Ligands , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/metabolism , P-Selectin/immunology , P-Selectin/pharmacology , Peptide Fragments/pharmacology , Platelet Aggregation/drug effects , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Platelet Membrane Glycoproteins/antagonists & inhibitors , Platelet Membrane Glycoproteins/metabolism , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/pharmacology
7.
Circulation ; 108(17): 2082-7, 2003 Oct 28.
Article in English | MEDLINE | ID: mdl-14530197

ABSTRACT

BACKGROUND: Sulfatides are sulfated glycosphingolipids expressed on the surface of erythrocytes, leukocytes, and platelets. Sulfatides interact with several cell adhesion molecules involved in hemostasis. Beta2-glycoprotein I is an anionic phospholipid-binding plasma protein, and the phospholipid-bound form is the target for most anti-phospholipid antibodies that are associated with recurrent thrombosis, miscarriages, and neurological symptoms. In this study, we examined whether beta2-glycoprotein I forms a complex with sulfatides and thereby becomes a target for anti-phospholipid antibodies. METHODS AND RESULTS: Beta2-glycoprotein I binds to surface-bound sulfatides but not to other glycolipids, such as ceramide, cerebrosides, sphingomyelin, or ganglioside. At a sulfatide coating density of 1 microg/well, beta2-glycoprotein I reaches half-maximal binding at 2.5 microg/mL, and the binding is saturated at 10 microg/mL. The binding of beta2-glycoprotein I also depends on the coating density of sulfatides in the well. At a constant beta2-glycoprotein I concentration of 5 microg/mL, maximal binding of beta2-glycoprotein I is observed at a coating density of 1 mug/well. The serum from 14 patients with anti-cardiolipin antibodies, a subset of anti-phospholipid antibodies, bound to sulfatide-bound beta2-glycoprotein I and previous absorption on cardiolipin-coated surfaces decreased the immunoreactivity toward sulfatide-beta2-glycoprotein I complex by >50% in 12 of 14 patients. Furthermore, immunoaffinity-purified anti-cardiolipin antibodies from 4 of 5 patients reacted with sulfatide-bound beta2-glycoprotein I. CONCLUSIONS: These results show that not only anionic phospholipids, as commonly known, but also sulfatides are targets for most anti-phospholipid antibodies. We therefore postulate that interactions of these antibodies with sulfatides may contribute to some of the clinical symptoms of the anti-phospholipid antibody syndrome.


Subject(s)
Antibodies, Antiphospholipid/metabolism , Antiphospholipid Syndrome/immunology , Lupus Erythematosus, Systemic/immunology , Sulfoglycosphingolipids/immunology , Antibodies, Anticardiolipin/blood , Antiphospholipid Syndrome/blood , Cardiolipins/immunology , Cardiolipins/metabolism , Enzyme-Linked Immunosorbent Assay , Glycoproteins/chemistry , Glycoproteins/metabolism , Humans , Immunosorbent Techniques , Liposomes/chemistry , Lupus Erythematosus, Systemic/blood , Macromolecular Substances , Protein Binding/physiology , Sjogren's Syndrome/blood , Sjogren's Syndrome/immunology , Sulfoglycosphingolipids/chemistry , beta 2-Glycoprotein I
8.
Circulation ; 102(17): 2045-50, 2000 Oct 24.
Article in English | MEDLINE | ID: mdl-11044418

ABSTRACT

BACKGROUND: P-selectin, expressed on platelets on activation, mediates rolling of platelets on endothelial cells, but its role in shear-induced platelet aggregation is not known. METHODS AND RESULTS: Platelets were exposed to either a single pulse (30 seconds) or 3 pulses (10 seconds) of high shear stress (150 to 200 dynes/cm(2)) each followed by low shear stress (10 dynes/cm(2)) for 4.5 minutes or 90 seconds, respectively, at 37 degrees C to resemble more closely in vivo conditions such as those in stenotic arteries. Under these conditions, platelet aggregation was significantly increased compared with low or high shear stress alone. Monoclonal anti-P-selectin antibodies inhibited shear-induced platelet aggregation, especially when induced by the combination of high and low shear stress, by approximately 70% and had an additive effect on the inhibition by abciximab (anti-glycoprotein (GP) IIb/IIIa antibody). However, anti-P-selectin antibody inhibited shear-induced platelet aggregation only at 37 degrees C, not at 22 degrees C, whereas abciximab inhibited shear-induced platelet aggregation at both 22 degrees C and 37 degrees C. This differential effect of anti-P-selectin antibody is explained by the finding that shear-induced P-selectin expression on platelets was observed mainly at 37 degrees C. CONCLUSIONS: These results indicate that pulsatile shear stress, which resembles flow conditions in stenotic arteries, induces significantly more platelet aggregation at 37 degrees C than monophasic shear stress. Under these conditions, we show a novel role for P-selectin in platelet aggregation distinct from that of GP IIb/IIIa, which may be of importance in the initiation of thrombosis associated with atherosclerotic lesions.


Subject(s)
P-Selectin/physiology , Platelet Aggregation/physiology , Analysis of Variance , Antibodies/immunology , Blood Platelets/metabolism , CD36 Antigens/immunology , Flow Cytometry , Humans , In Vitro Techniques , P-Selectin/immunology , Platelet Aggregation/immunology , Platelet Glycoprotein GPIIb-IIIa Complex/immunology , Temperature
9.
J Mol Med (Berl) ; 74(3): 161-5, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8846167

ABSTRACT

The accumulation of blood monocytes at sites of predilection of the vessel wall is an early cellular event of atherogenesis. Proteins of the vessel wall may facilitate monocyte adhesion and thus promote their recruitment. It has been shown that the relative content of extracellular fibrinogen increases during lesion development, and this study investigated the contribution of immobilized fibrinogen to monocyte adhesion and the underlying mechanism. Freshly isolated human blood monocytes were cultivated in serum-free RPMI 1640 in tissue culture wells precoated with albumin, fibrinogen, or fibrin. After 16 h the plates were washed and adherent cells enumerated. Immobilized fibrinogen enhanced monocyte adhesion more than 1.9-fold compared to immobilized albumin or fibrin (P < 0.05). Concomitant addition of the protein kinase C (PKC) inhibitors staurosporine or H7 suppressed monocyte adherence to immobilized fibrinogen but exerted no significant effect upon adhesion to any other surface tested. Stimulation of monocytes using phorbol myristate acetate resulted in increased binding of monocytes on fibrinogen but not on bovine serum albumin. When PKC activity was reduced through prolonged incubation with PMA for 16 h, a significant reduction of monocyte adhesion on fibrinogen was observed. Peptides containing RGD sequences, which have been demonstrated to be ligands for certain integrins, did not inhibit monocyte adhesion. The data suggest that fibrinogen promotes monocyte adhesion in vitro by a PKC-dependent mechanism. PKC appears to be important not only for the initial cell adhesion but also for sustained binding of monocytes to fibrinogen.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Cell Adhesion/drug effects , Fibrinogen/pharmacology , Monocytes/drug effects , Protein Kinase C/metabolism , Albumins/pharmacology , Alkaloids/pharmacology , Cells, Cultured , Fibrin/pharmacology , Humans , Isoquinolines/pharmacology , Monocytes/cytology , Monocytes/metabolism , Piperazines/pharmacology , Protein Kinase C/antagonists & inhibitors , Signal Transduction , Staurosporine , Tetradecanoylphorbol Acetate/pharmacology
10.
FEBS Lett ; 393(2-3): 264-8, 1996 Sep 16.
Article in English | MEDLINE | ID: mdl-8814302

ABSTRACT

The response of confluent monolayers of normal and cystic fibrosis (CF) pancreatic epithelial cells to stimulation by extracellular ATP and ATP analogues was investigated in terms of mucin secretion. Mucin secretion was measured as release of M1 antigens by a direct sandwich enzyme immunoassay. Extracellular ATP provoked rapid (< or = 15 min) and strong mucin secretion (+ 480 +/- 35%) by the normal pancreatic cell lines but was not able to induce mucin secretion by the CF cell lines. The order of efficacy of nucleotide agonists with ATP > ADP > AMP > adenosine was that of typical P2-purinergic receptors. ATP induced a rapid and transient intracellular [Ca2+] mobilization in both normal and CF pancreatic epithelial cells. This work demonstrated that CFTR seemed to mediate ATP-dependent mucin secretion.


Subject(s)
Adenosine Triphosphate/pharmacology , Cystic Fibrosis/physiopathology , Mucins/metabolism , Adenocarcinoma , Adenosine/pharmacology , Adenosine Diphosphate/pharmacology , Adenosine Monophosphate/pharmacology , Adult , Antigens/analysis , Calcium/metabolism , Carbachol/pharmacology , Cell Line , Colforsin/pharmacology , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Epithelium/physiology , Humans , Immunoassay , Mucins/analysis , Pancreatic Neoplasms , Receptors, Purinergic P2/physiology , Transfection , Tumor Cells, Cultured , Vasoactive Intestinal Peptide/pharmacology
11.
FEBS Lett ; 369(2-3): 202-6, 1995 Aug 07.
Article in English | MEDLINE | ID: mdl-7649258

ABSTRACT

Human tracheal glands are considered as the principle secretory structures in the bronchotracheal tree. In earlier studies, we successfully performed primary cultures of human tracheal gland (HTG) serous cells and noted that these cells were responsive to many secretagogues including purinergic agonists but not to the inflammatory mediator adenosine. In this study, we demonstrate that adenosine was capable of including stimulation of protein secretion by HTG serous cells which had previously been cultured in pro-inflammatory conditions (induced by lipopolysaccharide (LPS)). This stimulation was inhibited by 8-phenyltheophyllline but not by dipyridamole, which is indicative of a P1 purinoceptor. This inducible receptor is the adenosine A2 subtype [rank potency order: (5'-(N-ethyl)-carboxamidoadenosine (NECA) > adenosine > N6-(phenylisopropyl)-adenosine (PIA); and stimulation of adenylyl cyclase]. The adenosine-induced protein secretion was concentration-dependent, however, increased intracellular cyclic adenosine monophosphate (cAMP) was not dependent on the concentration of adenosine. The adenosine-induced secretion and the ATP-induced secretion were shown to be additive. This study concludes that there is evidence of a LPS-inducible adenosine A2 receptor in human tracheal gland serous cells.


Subject(s)
Exocrine Glands/drug effects , Lipopolysaccharides/pharmacology , Proteins , Receptors, Purinergic P1/biosynthesis , Trachea/drug effects , Adenosine/analogs & derivatives , Adenosine/pharmacology , Adenosine-5'-(N-ethylcarboxamide) , Cells, Cultured , Cyclic AMP/biosynthesis , Dipyridamole/pharmacology , Exocrine Glands/cytology , Exocrine Glands/metabolism , Humans , Phenylisopropyladenosine/pharmacology , Proteinase Inhibitory Proteins, Secretory , Purinergic P1 Receptor Antagonists , Receptors, Purinergic P1/metabolism , Serine Proteinase Inhibitors/metabolism , Theophylline/analogs & derivatives , Theophylline/pharmacology , Trachea/cytology , Trachea/metabolism
12.
FEBS Lett ; 321(1): 73-8, 1993 Apr 19.
Article in English | MEDLINE | ID: mdl-7682188

ABSTRACT

Human tracheal gland cells are believed to be a major site at the origin of cystic fibrosis. Since this disease is due to mutations in a protein called CFTR, we looked for the activity of CFTR in human tracheal gland cells in culture. We have identified CFTR-like chloride-selective channels as having a linear current voltage relationship and unitary conductance of 7 pS in these cells. In cell-attached patches, theophylline (1 mM), IBMX (1 mM), or a cocktail of dibutyryl cAMP (1 mM) and IBMX (0.1 mM) promoted the opening of channels. The unitary current had a reversal potential close to the cell resting potential. Replacement of choline by K+ or Na+ in the pipette solution was without effect on the current-voltage relationship, the reversal potential or the unitary conductance, which is consistent with the chloride selectivity of the channel. Channels were always found clustered and their opening probability was not noticeably dependent on membrane potential. This work therefore represents the first observation of a CFTR-like channel activity in submucosal gland cells.


Subject(s)
Membrane Proteins/metabolism , Trachea/metabolism , Base Sequence , Cyclic AMP/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator , Electric Conductivity , Gene Expression , Humans , In Vitro Techniques , Membrane Proteins/genetics , Molecular Sequence Data , Oligodeoxyribonucleotides/chemistry , RNA, Messenger/genetics , Trachea/anatomy & histology , Trachea/chemistry
13.
FEBS Lett ; 327(3): 337-42, 1993 Aug 02.
Article in English | MEDLINE | ID: mdl-7688697

ABSTRACT

We have studied CFTR-Cl- channels in non-CF CAPAN-1 and in CFTR-transfected CFPAC-PLJ-CFTR-6 epithelial cells from human pancreas. Theophylline and IBMX induced the opening of cell-attached CFTR-Cl- channels. Theophylline, IBMX and the alkaline phosphatase (AP) inhibitor levamisole enhanced the activity of excised channels and reduced by 70-75% the apical membrane-associated APs activity. Okadaic acid had no effect on APs and channel activities. A polyclonal anti-alkaline phosphatase antibody (which detected apical APs) reduced APs activity and activated quiescent excised chloride channels. These results suggest that CFTR channels may be regulated by membrane-bound phosphatases.


Subject(s)
Alkaline Phosphatase/physiology , Cystic Fibrosis/metabolism , Membrane Proteins/metabolism , Membrane Proteins/physiology , Pancreas/enzymology , 1-Methyl-3-isobutylxanthine/pharmacology , Base Sequence , Chloride Channels , Chlorides/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator , DNA, Single-Stranded , Humans , Ion Channels/drug effects , Ion Channels/metabolism , Membrane Potentials , Membrane Proteins/chemistry , Membrane Proteins/drug effects , Membrane Proteins/genetics , Molecular Sequence Data , Pancreas/cytology , Pancreas/physiology , Theophylline/pharmacology , Tumor Cells, Cultured
14.
FEBS Lett ; 386(2-3): 123-7, 1996 May 20.
Article in English | MEDLINE | ID: mdl-8647265

ABSTRACT

This study documents a difference between cystic fibrosis human (CF-HTG) and normal human (HTG) tracheal gland cells: the ability of histamine to induce an increase of intracellular free calcium concentration [Ca2+]i was abnormally reduced in CF-HTG cells. The magnitude of the [Ca2+]i peak rise in response to histamine is smaller in CF-HTG cells than in HTG cells, and the percentage of CF-HTG cells that increase [Ca2+]i is decreased compared with HTG cells. In contrast to histamine, the human neutrophil elastase (HNE) stimulation of both CF-HTG and HTG cells generated [Ca2+]i asynchronous oscillations and the magnitude of the peak [Ca2+]i response as well as the percentage of responding cells were similar for both groups. By videomicroscopy observations, the secretory response (exocytosis of secretion granules) of CF-HTG cells occurred with HNE, but not with histamine, thus suggesting that [Ca2+]i asynchronous oscillations may be linked to the exocytosis process in human tracheal gland cells.


Subject(s)
Calcium/metabolism , Cystic Fibrosis/metabolism , Histamine/pharmacology , Trachea/metabolism , Calcimycin/analogs & derivatives , Calcimycin/pharmacology , Cells, Cultured , Cystic Fibrosis/pathology , Humans , Ionophores/pharmacology , Leukocyte Elastase , Pancreatic Elastase/pharmacology , Trachea/cytology , Trachea/drug effects
15.
FEBS Lett ; 294(3): 175-8, 1991 Dec 09.
Article in English | MEDLINE | ID: mdl-1756857

ABSTRACT

Proteins with trypsin-like immunoreactivity (first detected by a specific immunoenzymatic assay) were isolated from CAPAN-1 and CFPAC-1 cell culture-conditioned media by chromatography on an immunoadsorbent prepared with a polyclonal antibody directed against trypsin 1. The adsorbed proteins were devoid of free trypsin activity but trypsin activity was present after enterokinase activation demonstrating that the immunoreactive trypsin present in cell supernatants corresponds to trypsinogens. When characterised by Western blotting using a monoclonal antibody directed against human trypsin 1 two protein bands corresponding to trypsinogen 1 (23 kDa) and trypsinogen 2 (25 kDa) gave a positive reaction. These results demonstrate the presence of trypsinogens 1 and 2 in CAPAN-1 and CFPAC-1 cells and in their culture-conditioned media.


Subject(s)
Adenocarcinoma/enzymology , Pancreatic Neoplasms/enzymology , Trypsinogen/metabolism , Blotting, Western , Cell Line , Enteropeptidase/pharmacology , Enzyme Activation/drug effects , Humans , Molecular Weight , Trypsin/isolation & purification , Trypsin/metabolism , Trypsinogen/isolation & purification , Tumor Cells, Cultured
16.
J Comp Neurol ; 382(2): 230-46, 1997 Jun 02.
Article in English | MEDLINE | ID: mdl-9183691

ABSTRACT

To better understand the dynamics of the cellular processes involved in early neocortical development, we studied the neuritic differentiation and synaptogenesis of dispersed neurons grown in serum-free cultures under a wide variety of culture conditions. Microtubule-associated protein (MAP2), phosphorylated neurofilament (SMI 31) and synaptophysin immunocytochemistry was complemented with time-lapse studies. During the first week in vitro dissociated cortical neurons developed from roundish cells without processes to neurons with axons and differentiated dendrites, going through five distinct phases. The sequence of these phases was unaltered in a wide range of culturing methods, but the timing of the steps varied among cultures started with different cell densities. Synaptic terminals were first observed after 3-4 days in vitro, coincident with the beginning of dendritic differentiation. Synaptogenesis progressed at least until the end of the third week in vitro, despite a decline in cell density during the second week in vitro. The process of cellular differentiation of cerebral cortical neurons in vitro resembled the development of these cells in the intact tissue, suggesting that organized cell migration is not a prerequisite for the differentiation of single cortical neurons.


Subject(s)
Astrocytes/cytology , Cerebral Cortex/cytology , Neurites/ultrastructure , Neurons/cytology , Synapses/ultrastructure , Animals , Animals, Newborn , Astrocytes/physiology , Biomarkers , Cell Differentiation , Cell Movement , Cells, Cultured , Culture Media, Serum-Free , Immunohistochemistry , Microtubule-Associated Proteins/analysis , Microtubule-Associated Proteins/biosynthesis , Neurites/physiology , Neurofilament Proteins/biosynthesis , Neurons/physiology , Rats , Rats, Sprague-Dawley , Synapses/physiology , Synaptophysin/analysis , Synaptophysin/biosynthesis , Time Factors
17.
Biochimie ; 83(8): 749-55, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11530207

ABSTRACT

Human tracheal glands cells (HTGC) in culture are able to respond to adrenergic, cholinergic and purinergic agonists by increasing their serous and mucin secretions. These secretagogues are also able to maintain an optimal responsiveness of serous cells to stimulation when they are regularly and briefly delivered to the cells, making the HTGC a suitable model to study the serous secretion (Merten, in press). Our interest has been focused on the effects of cholinergic and purinergic secretagogues associated to histamine, on the mucous function of the transformed human tracheal gland cell line MM-39, which has a mixed, both serous and mucous, phenotype. When the cells were exposed to short stimulation every 2 days for 3 weeks with 10 or 100 microM carbachol, UTP and histamine, modifications of their mucous phenotype were observed. The expression of MUC genes appeared dependent on the culture conditions. Transcripts of MUC1, MUC4, and MUC5B genes were observed when the cells were regularly exposed to the mixture of secretagogues at a concentration of 10 microM, in contrast to the unstimulated expression of MUC1 and MUC4 in control cells. MUC1, MUC4, MUC7, MUC6 and MUC11 transcripts were observed when the cells were regularly exposed to the mixture of secretagogues at a concentration of 100 microM. These culture conditions were also able to induce an alpha 1,2-fucosyltransferase activity absent in the MM-39 cells cultivated with standard conditions. There was no marked effect on the alpha 2,3-sialyltransferase activity although the expression pattern of the sialyltransferase genes was reduced to the unique presence of ST3Gal III. In conclusion, MM-39 cells exposed to repeated stimulation by secretagogues at different concentrations express different sero-mucous phenotypes.


Subject(s)
Cell Culture Techniques/methods , Fucosyltransferases/genetics , Gene Expression , Mucins/genetics , Animals , Cattle , Cell Line, Transformed , Humans , Mucin-1/genetics , Mucin-4 , Mucin-5B , Mucin-6 , Peptide Fragments/genetics , Salivary Proteins and Peptides/genetics , Sialyltransferases/genetics , Trachea/cytology , beta-Galactoside alpha-2,3-Sialyltransferase , Galactoside 2-alpha-L-fucosyltransferase
18.
Brain Res ; 671(2): 317-20, 1995 Feb 13.
Article in English | MEDLINE | ID: mdl-7743222

ABSTRACT

To analyse the influences of estradiol on the differentiation of neurons in the song motor centers RA (robust nucleus of the archistriatum) and HVc (higher vocal center), juvenile male zebra finches were treated with the aromatase inhibitor, Fadrozole (CGS 16949A). The differentiation of neurons was determined by measuring neuronal soma sizes. As adults the treated animals showed a significant shift in the distribution of neuron sizes towards smaller cell diameters in both areas. The neuroanatomical modulation caused by Fadrozole was not accompanied by changes in song behaviour.


Subject(s)
Birds/physiology , Brain/drug effects , Fadrozole/pharmacology , Neurons/drug effects , Vocalization, Animal/drug effects , Animals , Brain/anatomy & histology , Brain/cytology , Cell Differentiation/drug effects , Cell Size/drug effects , Male , Neurons/ultrastructure
19.
Eur J Pharmacol ; 384(1): 91-8, 1999 Nov 12.
Article in English | MEDLINE | ID: mdl-10611424

ABSTRACT

Human submucosal tracheal glands are now believed to play a major role in the physiopathology of cystic fibrosis, a genetic disease in which ATP is used as a therapeutic agent. However, actions of ATP on tracheal gland cells are not well known. ATP binds to P2 receptors and induced secretory leucocyte protease inhibitor (SLPI) secretion through formation of cyclic adenosine monophosphate and mobilization of intracellular [Ca(2+)]. Since diadenosine polyphosphates (ApnA) are also endogenous effectors of P2 receptors, we investigated their effects in a cell line (MM39) of human tracheal gland cells. Diadenosine tetraphosphates (Ap4A) induced significant stimulation (+50+/-12%) of SLPI secretion and to a similar extent to that of ATP (+65+/-10%). No significant effects were observed with diadenosine triphosphate (Ap3A), diadenosine pentaphosphate (Ap5A), ADP and 2-methylthio-adenosine triphosphate (2-MeS-ATP). Since Ap4A was weakly hydrolyzed (<2% of total), and the hydrolysis product was only inosine which is ineffective on cells, this Ap4A effect was not due to Ap4A hydrolysis in ATP and adenosine monophosphate (AMP). A mixture of Ap4A and ATP elicited only partial additive effects on SLPI secretion. ADP was shown to be a potent antagonist of ATP and Ap4A receptors, with IC(50)s of 0.8 and 2 microM, respectively. 2-MeS-ATP also showed antagonistic properties with IC(50)s of 20 and 30 microM for ATP- and Ap4A-receptors, respectively. Single cell intracellular calcium ([Ca(2+)](i)) measurements showed similar transient increases of [Ca(2+)](i) after ATP or Ap4A challenges. ATP desensitized the cell [Ca(2+)](i) responses to ATP and Ap4A, and Ap4A also desensitized the cell response to Ap4A. Nevertheless, Ap4A did not desensitize the cell [Ca(2+)](i) responses to ATP. In conclusion, both P2Y2-ATP-receptors and Ap4A-P2D-receptors seem to be present in tracheal gland cells. Ap4A may only bind to P2D-receptors whilst ATP may bind to both Ap4A- and ATP-receptors.


Subject(s)
Receptors, Purinergic P2/metabolism , Trachea/metabolism , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Binding, Competitive/drug effects , Calcium/metabolism , Cells, Cultured , Dinucleoside Phosphates/metabolism , Dinucleoside Phosphates/pharmacology , Dose-Response Relationship, Drug , Humans , Hydrolysis , Proteinase Inhibitory Proteins, Secretory , Proteins/drug effects , Proteins/metabolism , Secretory Leukocyte Peptidase Inhibitor , Suramin/pharmacology , Thionucleotides/pharmacology , Trachea/cytology , Trachea/drug effects
20.
Methods Mol Med ; 2: 201-16, 1996.
Article in English | MEDLINE | ID: mdl-21359745

ABSTRACT

For several years, tracheal gland cells have been cultured from different animal species, such as the cat (1), cow (2), and ferret (3). There are dlffer ences, however, in the structure and function of the various animal airways, rendering it difficult to extrapolate to humans. In this chapter, the author describes techniques that facilitate the isolation and culture of tracheal gland cells from humans. These techniques allow high reproducibility, optimal cell isolation, and high phenotypic expression, rendering them appropriate for physiological, pharmacological, and biomedical applications.

SELECTION OF CITATIONS
SEARCH DETAIL